CHI3L1 and liver cancer: On the other hand, CHI3L1 may negatively regulate S100A9 and S100A4, which means that its interaction with S100A9 and S100A4 results in a reduction in the proinflammatory effects of S100A9 and S100A4 in liver cancer.